MedTrace Logo

Advanced Imaging for Glaucoma Study

NCT01314326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 832

Last updated 2018-04-12

No results posted yet for this study

Summary

The specific aims of the clinical studies are to:

1. Predict the development of glaucomatous visual field (VF) abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic abnormalities detected by advanced imaging.
2. Predict the development of glaucomatous VF abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic changes detected between successive advanced imaging tests.
3. Determine the sensitivity and specificity of glaucoma diagnosis based on advanced imaging tests.

Conditions

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • David Huang, MD, PhD · Oregon Health and Science University

  • Joel S. Schuman, MD · University of Pittsburgh

  • Rohit Varma, MD · University of Southern California

  • David S. Greenfield, MD · University of Miami

  • John Morrison, MD · Oregon Health and Science University

  • James Fujimoto, PhD · Massachusettes Inistitute of Technology

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2015-05-15
Completion
2015-05-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01314326 on ClinicalTrials.gov